Company Filing History:
Years Active: 1997-2001
Title: John Harrison Heiligenstein: Innovator in Behavioral Treatment
Introduction
John Harrison Heiligenstein is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of behavioral health, particularly in the treatment of conduct disorder and attention-deficit/hyperactivity disorder. With a total of five patents to his name, Heiligenstein's work has had a profound impact on therapeutic practices.
Latest Patents
Heiligenstein's latest patents include innovative treatments that utilize norepinephrine reuptake inhibitors for conduct disorder. Additionally, he has developed methods for treating attention-deficit/hyperactivity disorder using reboxetine. These advancements highlight his commitment to improving mental health treatment options.
Career Highlights
Heiligenstein is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in various therapeutic areas. His work at Eli Lilly has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Heiligenstein has worked alongside notable colleagues such as Gary Dennis Tollefson and Bennett C Laguzza. Their combined expertise has fostered an environment of innovation and progress in behavioral health treatments.
Conclusion
John Harrison Heiligenstein's contributions to the field of behavioral health through his patents and collaborations underscore his role as a key innovator. His work continues to influence treatment methodologies and improve the lives of those affected by behavioral disorders.